Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
Thomson Pharma


 
Discover. Develop. Launch. Innovate.

Thomson PharmaSM is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. It will provide a powerful gateway to an unrivalled portfolio of patent, scientific, and financial information products and services from across the full range of Thomson-owned businesses.

Through a single, customizable interface, you will be able to browse and search multiple sources of content relevant to the pharmaceutical industry and obtain single, easy-to-read reports that incorporate select information pulled from a wide range of sources.

The key areas of content will include:

  • Drugs
  • Intellectual Property
  • Literature & News
  • Companies
  • Targets
  • Chemistry
  • Sequences

Developing the complete pharmaceutical solution

The Thomson Corporation possesses an extensive collection of scientific, healthcare, legal, and financial information products, tools, and services that are relevant to the pharmaceutical industry.

Thomson Pharma will link these offerings together and enable searching and browsing across multiple databases. It will meet the information needs of anyone working within the drug development pipeline, from discovery chemists at the beginning of the process to sales and marketing at the end.

Providing key functionality

Using Thomson Pharma, it will be easy to search for, browse, and analyze data. The solution will include powerful features and functionality, including:

  • Cross-file searching
  • Browsing by text and structure
  • Interfaces configurable by disease, therapy, or franchise area and line of business
  • Customizable content selection
  • User friendly guided searches

Sophisticated analysis tools

Further information will be released as Thomson Pharma evolves.




 


 

Additional Information
Click here to download the latest Thomson Pharma fact sheet

 
Disclaimer | Terms of Use
Privacy Policy | Copyright